{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:57:18Z","timestamp":1775041038320,"version":"3.50.1"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Deanship of Research and Graduate Studies, King Khalid University, Abha, Saudi Arabia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-026-02217-6","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T03:03:39Z","timestamp":1775012619000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Involvement of the PD-1 pathway in the modulation of immune responses during allergic diseases"],"prefix":"10.1007","volume":"75","author":[{"given":"Asma\u2019a Hassan","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rithab Ibrahim","family":"Al-Samawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Chand","family":"Jamali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana","family":"Abdul-Jabbar Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayyub Ali","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alam Eldin Musa","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulrahman Samir","family":"Khairallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasrin","family":"Mansuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashit Kumar","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Zulfiqah","family":"Sadikan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaid H.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"2217_CR1","unstructured":"Diagnosed Allergic Conditions in Adults: United States. 2021, (2023)."},{"issue":"5","key":"2217_CR2","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1080\/14737167.2020.1819793","volume":"20","author":"BJH Dierick","year":"2020","unstructured":"Dierick BJH, van der Molen T, Flokstra-de Blok BMJ, et al. Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy. Expert Rev Pharmacoecon Outcomes Res. 2020;20(5):437\u201353.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"3","key":"2217_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41423-025-01261-2","volume":"22","author":"I Ogulur","year":"2025","unstructured":"Ogulur I, Mitamura Y, Yazici D, et al. Type 2 immunity in allergic diseases. Cell Mol Immunol. 2025;22(3):211\u201342.","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"2217_CR4","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s12276-020-0435-8","volume":"52","author":"J-R Hwang","year":"2020","unstructured":"Hwang J-R, Byeon Y, Kim D, et al. Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development. Exp Mol Med. 2020;52(5):750\u201361.","journal-title":"Exp Mol Med"},{"issue":"9","key":"2217_CR5","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nri3728","volume":"14","author":"M Lever","year":"2014","unstructured":"Lever M, Maini PK, Van Der Merwe PA, et al. Phenotypic models of T cell activation. Nat Rev Immunol. 2014;14(9):619\u201329.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2217_CR6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12(4):252\u201364.","journal-title":"Nat Rev Cancer"},{"key":"2217_CR7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3389\/fimmu.2020.00487","volume":"11","author":"JM Jubel","year":"2020","unstructured":"Jubel JM, Barbati ZR, Burger C, et al. The role of PD-1 in acute and chronic infection. Front Immunol. 2020;11:487.","journal-title":"Front Immunol"},{"issue":"8","key":"2217_CR8","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","volume":"30","author":"X He","year":"2020","unstructured":"He X, Xu C. Immune checkpoint signaling and cancer immunotherapy. Cell Res. 2020;30(8):660\u20139.","journal-title":"Cell Res"},{"issue":"1","key":"2217_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jid.2021.06.026","volume":"142","author":"R Tanaka","year":"2022","unstructured":"Tanaka R, Ichimura Y, Kubota N, et al. Differential Involvement of programmed cell death ligands in skin immune responses. J Invest Dermatol. 2022;142(1):145\u2013e1548.","journal-title":"J Invest Dermatol"},{"issue":"21","key":"2217_CR10","doi-asserted-by":"publisher","first-page":"11898","DOI":"10.3390\/ijms222111898","volume":"22","author":"MA Galv\u00e1n Morales","year":"2021","unstructured":"Galv\u00e1n Morales MA, Montero-Vargas JM, Vizuet-de-Rueda JC, et al. New insights into the role of PD-1 and its ligands in allergic disease. Int J Mol Sci. 2021;22(21):11898.","journal-title":"Int J Mol Sci"},{"issue":"38","key":"2217_CR11","doi-asserted-by":"publisher","first-page":"eabd2712","DOI":"10.1126\/sciadv.abd2712","volume":"6","author":"N Patsoukis","year":"2020","unstructured":"Patsoukis N, Wang Q, Strauss L, et al. Revisiting the PD-1 pathway. Sci Adv. 2020;6(38):eabd2712.","journal-title":"Sci Adv"},{"issue":"8","key":"2217_CR12","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.str.2017.06.011","volume":"25","author":"KM Zak","year":"2017","unstructured":"Zak KM, Grudnik P, Magiera K, et al. Structural biology of the immune checkpoint receptor PD-1 and its ligands PD-L1\/PD-L2. Structure. 2017;25(8):1163\u201374.","journal-title":"Structure"},{"issue":"3","key":"2217_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1074-7613(04)00051-2","volume":"20","author":"X Zhang","year":"2004","unstructured":"Zhang X, Schwartz J-CD, Guo X, et al. Structural and functional analysis of the costimulatory receptor programmed death-1. Immunity. 2004;20(3):337\u201347.","journal-title":"Immunity"},{"issue":"18","key":"2217_CR14","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMra1514296","volume":"375","author":"VA Boussiotis","year":"2016","unstructured":"Boussiotis VA. Molecular and biochemical aspects of the PD-1 checkpoint pathway. N Engl J Med. 2016;375(18):1767\u201378.","journal-title":"N Engl J Med"},{"key":"2217_CR15","doi-asserted-by":"crossref","unstructured":"Pauken KE, Torchia JA, Chaudhri A, et al. editors. Emerging concepts in PD-1 checkpoint biology. Seminars in immunology. Elsevier; 2021.","DOI":"10.1016\/j.smim.2021.101480"},{"issue":"10","key":"2217_CR16","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1084\/jem.20061496","volume":"203","author":"C Petrovas","year":"2006","unstructured":"Petrovas C, Casazza JP, Brenchley JM, et al. PD-1 is a regulator of virus-specific CD8\u2009+\u2009T cell survival in HIV infection. J Exp Med. 2006;203(10):2281\u201392.","journal-title":"J Exp Med"},{"issue":"10","key":"2217_CR17","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1111\/j.1600-6143.2012.04224.x","volume":"12","author":"LV Riella","year":"2012","unstructured":"Riella LV, Paterson AM, Sharpe AH, et al. Role of the PD-1 pathway in the immune response. Am J Transplant. 2012;12(10):2575\u201387.","journal-title":"Am J Transplant"},{"issue":"3","key":"2217_CR18","first-page":"727","volume":"10","author":"Y Han","year":"2020","unstructured":"Han Y, Liu D, Li L. PD-1\/PD-L1 pathway: current researches in cancer. Am J cancer Res. 2020;10(3):727.","journal-title":"Am J cancer Res"},{"key":"2217_CR19","doi-asserted-by":"publisher","first-page":"964442","DOI":"10.3389\/fimmu.2022.964442","volume":"13","author":"Q Tang","year":"2022","unstructured":"Tang Q, Chen Y, Li X, et al. The role of PD-1\/PD-L1 and application of immune-checkpoint inhibitors in human cancers. Front Immunol. 2022;13:964442.","journal-title":"Front Immunol"},{"issue":"11","key":"2217_CR20","doi-asserted-by":"publisher","first-page":"104181","DOI":"10.1016\/j.drudis.2024.104181","volume":"29","author":"L Hu","year":"2024","unstructured":"Hu L, Sun C, Yuan K, et al. Expression, regulation, and function of PD-L1 on non-tumor cells in the tumor microenvironment. Drug Discov Today. 2024;29(11):104181.","journal-title":"Drug Discov Today"},{"issue":"1","key":"2217_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0165-2478(02)00142-6","volume":"84","author":"M Ishida","year":"2002","unstructured":"Ishida M, Iwai Y, Tanaka Y, et al. Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. Immunol Lett. 2002;84(1):57\u201362.","journal-title":"Immunol Lett"},{"key":"2217_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1134\/S1068162019040101","volume":"45","author":"A Chapoval","year":"2019","unstructured":"Chapoval A, Chapoval S, Shcherbakova N, et al. Immune checkpoints of the B7 family. Part 1. General characteristics and first representatives: B7-1, B7-2, B7-H1, B7-H2, and B7-DC. Russ J Bioorg Chem. 2019;45:225\u201340.","journal-title":"Russ J Bioorg Chem"},{"issue":"2","key":"2217_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.coi.2011.12.009","volume":"24","author":"SL Topalian","year":"2012","unstructured":"Topalian SL, Drake CG, Pardoll DM. Targeting the PD-1\/B7-H1 (PD-L1) pathway to activate anti-tumor immunity. Curr Opin Immunol. 2012;24(2):207\u201312.","journal-title":"Curr Opin Immunol"},{"issue":"328","key":"2217_CR24","doi-asserted-by":"publisher","first-page":"rv3284","DOI":"10.1126\/scitranslmed.aad7118","volume":"8","author":"W Zou","year":"2016","unstructured":"Zou W, Wolchok JD, Chen L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations. Sci Transl Med. 2016;8(328):rv3284\u20133284.","journal-title":"Sci Transl Med"},{"issue":"11","key":"2217_CR25","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3390\/cancers17111747","volume":"17","author":"M Mani","year":"2025","unstructured":"Mani M, Park JW, Martin TFJ. Regulatory mechanisms and therapeutic targeting of PD-L1 trafficking and stability in cancer immunotherapy. Cancers (Basel). 2025;17(11):1747.","journal-title":"Cancers (Basel)"},{"issue":"17","key":"2217_CR26","doi-asserted-by":"publisher","first-page":"11771","DOI":"10.1074\/jbc.M112.448126","volume":"288","author":"X Cheng","year":"2013","unstructured":"Cheng X, Veverka V, Radhakrishnan A, et al. Structure and interactions of the human programmed cell death 1 receptor. J Biol Chem. 2013;288(17):11771\u201385.","journal-title":"J Biol Chem"},{"issue":"1Supplement","key":"2217_CR27","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.4049\/jimmunol.202.Supp.185.2","volume":"202","author":"A Srinivasamani","year":"2019","unstructured":"Srinivasamani A, Liu Q, Curran M. PD-L2 generates a signal through the PD-1 co-receptor distinct from that of PD-L1. J Immunol. 2019;202(1Supplement):1852\u20131852.","journal-title":"J Immunol"},{"issue":"5502","key":"2217_CR28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1126\/science.291.5502.319","volume":"291","author":"H Nishimura","year":"2001","unstructured":"Nishimura H, Okazaki T, Tanaka Y, et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science. 2001;291(5502):319\u201322.","journal-title":"Science"},{"issue":"1","key":"2217_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1084\/jem.20022125","volume":"198","author":"MJ Ansari","year":"2003","unstructured":"Ansari MJ, Salama AD, Chitnis T, et al. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med. 2003;198(1):63\u20139.","journal-title":"J Exp Med"},{"issue":"65","key":"2217_CR30","doi-asserted-by":"publisher","first-page":"eabf4034","DOI":"10.1126\/sciimmunol.abf4034","volume":"6","author":"JR Kuchroo","year":"2021","unstructured":"Kuchroo JR, Hafler DA, Sharpe AH, et al. The double-edged sword: harnessing PD-1 blockade in tumor and autoimmunity. Sci Immunol. 2021;6(65):eabf4034.","journal-title":"Sci Immunol"},{"issue":"7203","key":"2217_CR31","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature07204","volume":"454","author":"SJ Galli","year":"2008","unstructured":"Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature. 2008;454(7203):445\u201354.","journal-title":"Nature"},{"key":"2217_CR32","doi-asserted-by":"publisher","first-page":"100995","DOI":"10.1016\/j.mam.2021.100995","volume":"85","author":"ZI Koml\u00f3si","year":"2022","unstructured":"Koml\u00f3si ZI, van de Veen W, Kov\u00e1cs N, et al. Cellular and molecular mechanisms of allergic asthma. Mol Aspects Med. 2022;85:100995.","journal-title":"Mol Aspects Med"},{"issue":"4","key":"2217_CR33","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/all.12828","volume":"71","author":"U Zissler","year":"2016","unstructured":"Zissler U, Esser-von Bieren J, Jakwerth C, et al. Current and future biomarkers in allergic asthma. Allergy. 2016;71(4):475\u201394.","journal-title":"Allergy"},{"issue":"6","key":"2217_CR34","doi-asserted-by":"publisher","first-page":"2002094","DOI":"10.1183\/13993003.02094-2020","volume":"56","author":"MI Asher","year":"2020","unstructured":"Asher MI, Garc\u00eda-Marcos L, Pearce NE, et al. Trends in worldwide asthma prevalence. Eur Respir J. 2020;56(6):2002094.","journal-title":"Eur Respir J"},{"issue":"1","key":"2217_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ni.3049","volume":"16","author":"BN Lambrecht","year":"2015","unstructured":"Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol. 2015;16(1):45\u201356.","journal-title":"Nat Immunol"},{"issue":"1","key":"2217_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02632-1","volume":"18","author":"MA Khan","year":"2020","unstructured":"Khan MA. Regulatory T cells mediated immunomodulation during asthma: a therapeutic standpoint. J Translational Med. 2020;18(1):1\u20138.","journal-title":"J Translational Med"},{"issue":"6","key":"2217_CR37","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jaci.2010.06.025","volume":"126","author":"DS Robinson","year":"2010","unstructured":"Robinson DS. The role of the T cell in asthma. J Allergy Clin Immunol. 2010;126(6):1081\u201391.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"2217_CR38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/ACI.0000000000000899","volume":"23","author":"KF Chung","year":"2023","unstructured":"Chung KF. Type-2-low severe asthma endotypes for new treatments: the new asthma frontier. Curr Opin Allergy Clin Immunol. 2023;23(3):199\u2013204.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"3","key":"2217_CR39","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000242355","volume":"151","author":"V Lombardi","year":"2010","unstructured":"Lombardi V, Singh AK, Akbari O. The role of costimulatory molecules in allergic disease and asthma. Int Arch Allergy Immunol. 2010;151(3):179\u201389.","journal-title":"Int Arch Allergy Immunol"},{"issue":"2","key":"2217_CR40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1398-9995.2010.02458.x","volume":"66","author":"AK Singh","year":"2011","unstructured":"Singh AK, Stock P, Akbari O. Role of PD-L1 and PD\u2010L2 in allergic diseases and asthma. Allergy. 2011;66(2):155\u201362.","journal-title":"Allergy"},{"issue":"8","key":"2217_CR41","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1136\/bjo.2006.091314","volume":"90","author":"A Fukushima","year":"2006","unstructured":"Fukushima A, Yamaguchi T, Azuma M, et al. Involvement of programmed death-ligand 2 (PD\u2010L2) in the development of experimental allergic conjunctivitis in mice. Br J Ophthalmol. 2006;90(8):1040.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"2217_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/mi.2009.112","volume":"3","author":"O Akbari","year":"2010","unstructured":"Akbari O, Stock P, Singh A, et al. PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions. Mucosal Immunol. 2010;3(1):81\u201391.","journal-title":"Mucosal Immunol"},{"issue":"4","key":"2217_CR43","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/mi.2012.111","volume":"6","author":"I Lewkowich","year":"2013","unstructured":"Lewkowich I, Lajoie S, Stoffers S, et al. PD-L2 modulates asthma severity by directly decreasing dendritic cell IL-12 production. Mucosal Immunol. 2013;6(4):728\u201339.","journal-title":"Mucosal Immunol"},{"issue":"4","key":"2217_CR44","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.4049\/jimmunol.172.4.2530","volume":"172","author":"K Matsumoto","year":"2004","unstructured":"Matsumoto K, Inoue H, Nakano T, et al. B7-DC regulates asthmatic response by an IFN-\u03b3-dependent mechanism. J Immunol. 2004;172(4):2530\u201341.","journal-title":"J Immunol"},{"issue":"7","key":"2217_CR45","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1084\/jem.193.7.839","volume":"193","author":"S-Y Tseng","year":"2001","unstructured":"Tseng S-Y, Otsuji M, Gorski K, et al. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med. 2001;193(7):839\u201346.","journal-title":"J Exp Med"},{"issue":"3","key":"2217_CR46","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/85330","volume":"2","author":"Y Latchman","year":"2001","unstructured":"Latchman Y, Wood CR, Chernova T, et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol. 2001;2(3):261\u20138.","journal-title":"Nat Immunol"},{"issue":"2","key":"2217_CR47","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jaci.2022.07.022","volume":"151","author":"DG Helou","year":"2023","unstructured":"Helou DG, Quach C, Fung M, et al. Human PD-1 agonist treatment alleviates neutrophilic asthma by reprogramming T cells. J Allergy Clin Immunol. 2023;151(2):526\u2013e5388.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"2217_CR48","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/eji.201444778","volume":"45","author":"JW McAlees","year":"2015","unstructured":"McAlees JW, Lajoie S, Dienger K, et al. Differential control of CD4\u2009+\u2009T-cell subsets by the PD\u20101\/PD\u2010L1 axis in a mouse model of allergic asthma. Eur J Immunol. 2015;45(4):1019\u201329.","journal-title":"Eur J Immunol"},{"issue":"5","key":"2217_CR49","doi-asserted-by":"publisher","first-page":"e3001272","DOI":"10.1371\/journal.pbio.3001272","volume":"19","author":"A Kazanova","year":"2021","unstructured":"Kazanova A, Rudd CE. Programmed cell death 1 ligand (PD-L1) on T cells generates Treg suppression from memory. PLoS Biol. 2021;19(5):e3001272.","journal-title":"PLoS Biol"},{"issue":"12","key":"2217_CR50","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.3390\/cells11121978","volume":"11","author":"P Nied\u017awiedzka-Rystwej","year":"2022","unstructured":"Nied\u017awiedzka-Rystwej P, Majchrzak A, Aksak-W\u0105s B, et al. Programmed cell death-1\/programmed cell death-1 ligand as prognostic markers of coronavirus disease 2019 severity. Cells. 2022;11(12):1978.","journal-title":"Cells"},{"issue":"3","key":"2217_CR51","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jaci.2016.06.003","volume":"138","author":"MN Rivas","year":"2016","unstructured":"Rivas MN, Chatila TA. Regulatory T cells in allergic diseases. J Allergy Clin Immunol. 2016;138(3):639\u201352.","journal-title":"J Allergy Clin Immunol"},{"key":"2217_CR52","first-page":"6012053","volume":"1","author":"D Calzada","year":"2018","unstructured":"Calzada D, Baos S, Cremades-Jimeno L, et al. Immunological mechanisms in allergic diseases and allergen tolerance: the role of treg cells. J Immunol Res. 2018;1:6012053.","journal-title":"J Immunol Res"},{"issue":"4","key":"2217_CR53","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1165\/rcmb.2009-0258OC","volume":"43","author":"HS McGee","year":"2010","unstructured":"McGee HS, Yagita H, Shao Z, et al. Programmed Death-1 antibody blocks therapeutic effects of T-regulatory cells in cockroach antigen-induced allergic asthma. Am J Respir Cell Mol Biol. 2010;43(4):432\u201342.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"2217_CR54","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1038\/s41467-020-17813-1","volume":"11","author":"DG Helou","year":"2020","unstructured":"Helou DG, Shafiei-Jahani P, Lo R, et al. PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity. Nat Commun. 2020;11(1):3998.","journal-title":"Nat Commun"},{"key":"2217_CR55","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.3389\/fimmu.2018.02306","volume":"9","author":"C Paluch","year":"2018","unstructured":"Paluch C, Santos AM, Anzilotti C, et al. Immune checkpoints as therapeutic targets in autoimmunity. Front Immunol. 2018;9:2306.","journal-title":"Front Immunol"},{"key":"2217_CR56","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.3389\/fimmu.2019.02298","volume":"10","author":"W Qin","year":"2019","unstructured":"Qin W, Hu L, Zhang X, et al. The diverse function of PD-1\/PD-L pathway beyond cancer. Front Immunol. 2019;10:2298.","journal-title":"Front Immunol"},{"issue":"3","key":"2217_CR57","doi-asserted-by":"publisher","first-page":"26061","DOI":"10.31083\/FBL26061","volume":"30","author":"J Fu","year":"2025","unstructured":"Fu J, Wang X. Improvement of RSV-induced asthma in mice: a study based on icariin-mediated PD-1. Front bioscience (Landmark edition). 2025;30(3):26061.","journal-title":"Front bioscience (Landmark edition)"},{"issue":"6","key":"2217_CR58","doi-asserted-by":"publisher","first-page":"e0038925","DOI":"10.1128\/msystems.00389-25","volume":"10","author":"J Huang","year":"2025","unstructured":"Huang J, Qiao H, Li Q, et al. Osteopontin protects from ovalbumin-induced asthma by preserving the microbiome and the intestinal barrier function. mSystems. 2025;10(6):e0038925.","journal-title":"mSystems"},{"issue":"1","key":"2217_CR59","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41572-020-00227-0","volume":"6","author":"J Bousquet","year":"2020","unstructured":"Bousquet J, Anto JM, Bachert C, et al. Allergic rhinitis. Nat Reviews Disease Primers. 2020;6(1):95.","journal-title":"Nat Reviews Disease Primers"},{"issue":"1","key":"2217_CR60","doi-asserted-by":"publisher","first-page":"e12013","DOI":"10.1002\/clt2.12013","volume":"11","author":"S Mikkelsen","year":"2021","unstructured":"Mikkelsen S, Dinh KM, Boldsen JK, et al. Combinations of self-reported rhinitis, conjunctivitis, and asthma predicts IgE sensitization in more than 25,000 Danes. Clin translational allergy. 2021;11(1):e12013.","journal-title":"Clin translational allergy"},{"key":"2217_CR61","doi-asserted-by":"publisher","first-page":"874114","DOI":"10.3389\/fmed.2022.874114","volume":"9","author":"SM Nur Husna","year":"2022","unstructured":"Nur Husna SM, Tan HT, Md Shukri N, et al. Allergic rhinitis: a clinical and pathophysiological overview. Front Med (Lausanne). 2022;9:874114.","journal-title":"Front Med (Lausanne)"},{"issue":"8","key":"2217_CR62","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2217\/imt-2021-0325","volume":"14","author":"RS Bumbacea","year":"2022","unstructured":"Bumbacea RS, Boustani R, Panaitescu C, et al. Mechanisms of allergen immunotherapy supporting its disease-modifying effect. Immunotherapy. 2022;14(8):627\u201338.","journal-title":"Immunotherapy"},{"issue":"1","key":"2217_CR63","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/cea.13769","volume":"51","author":"H Mpairwe","year":"2021","unstructured":"Mpairwe H, Nkurunungi G, Tumwesige P, et al. Risk factors associated with rhinitis, allergic conjunctivitis and eczema among schoolchildren in Uganda. Clin Experimental Allergy. 2021;51(1):108\u201319.","journal-title":"Clin Experimental Allergy"},{"key":"2217_CR64","doi-asserted-by":"crossref","unstructured":"Sin B, Togias A. Pathophysiology of allergic and nonallergic rhinitis. Proceedings of the American Thoracic Society. 2011;8(1):106\u2013114.","DOI":"10.1513\/pats.201008-057RN"},{"issue":"16","key":"2217_CR65","doi-asserted-by":"publisher","first-page":"5918","DOI":"10.3390\/ijms21165918","volume":"21","author":"A Bocanegra","year":"2020","unstructured":"Bocanegra A, Blanco E, Fernandez-Hinojal G, et al. PD-L1 in systemic immunity: unraveling its contribution to PD-1\/PD-L1 blockade immunotherapy. Int J Mol Sci. 2020;21(16):5918.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2217_CR66","first-page":"384","volume":"55","author":"S Wen","year":"2020","unstructured":"Wen S, Li F, Zhao F, et al. Programmed cell death protein 1 and its ligands regulate immune balance in allergic rhinitis. Zhonghua er bi yan hou tou Jing wai ke za zhi=. Chin J Otorhinolaryngol Head Neck Surg. 2020;55(4):384\u201390.","journal-title":"Chin J Otorhinolaryngol Head Neck Surg"},{"issue":"6","key":"2217_CR67","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/cea.12308","volume":"44","author":"C Shen","year":"2014","unstructured":"Shen C, Hupin C, Froidure A, et al. Impaired ICOSL in human myeloid dendritic cells promotes Th2 responses in patients with allergic rhinitis and asthma. Clin Experimental Allergy. 2014;44(6):831\u201341.","journal-title":"Clin Experimental Allergy"},{"issue":"2","key":"2217_CR68","doi-asserted-by":"publisher","first-page":"e12836","DOI":"10.1111\/sji.12836","volume":"91","author":"Z Wang","year":"2020","unstructured":"Wang Z, Tan F. The blockade of PD-1\/PD-L1 pathway promotes the apoptosis of CD19\u2009+\u2009CD25+ Bregs and suppresses the secretion of IL-10 in patients with allergic rhinitis. Scand J Immunol. 2020;91(2):e12836.","journal-title":"Scand J Immunol"},{"issue":"4","key":"2217_CR69","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1001\/archotol.134.4.424","volume":"134","author":"JH Wang","year":"2008","unstructured":"Wang JH, Kwon HJ, Chung Y-S, et al. Infection rate and virus-induced cytokine secretion in experimental rhinovirus infection in mucosal organ culture: comparison between specimens from patients with chronic rhinosinusitis with nasal polyps and those from normal subjects. Archives Otolaryngology\u2013Head Neck Surg. 2008;134(4):424\u20137.","journal-title":"Archives Otolaryngology\u2013Head Neck Surg"},{"issue":"2","key":"2217_CR70","doi-asserted-by":"publisher","first-page":"217","DOI":"10.21053\/ceo.2020.00444","volume":"14","author":"YK Ko","year":"2021","unstructured":"Ko YK, Zhang YL, Wee JH, et al. Human rhinovirus infection enhances the Th2 environment in allergic and non-allergic patients with chronic rhinosinusitis. Clin Exp Otorhinolaryngol. 2021;14(2):217\u201324.","journal-title":"Clin Exp Otorhinolaryngol"},{"issue":"6","key":"2217_CR71","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/all.13136","volume":"72","author":"I Kortekaas Krohn","year":"2017","unstructured":"Kortekaas Krohn I, Bobic S, Dooley J, et al. Programmed cell death-1 expression correlates with disease severity and IL-5 in chronic rhinosinusitis with nasal polyps. Allergy. 2017;72(6):985\u201393.","journal-title":"Allergy"},{"issue":"2","key":"2217_CR72","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.alit.2016.08.008","volume":"66","author":"R Nasiri Kalmarzi","year":"2017","unstructured":"Nasiri Kalmarzi R, Fattahi N, Kaviani Z, et al. Inverse correlation of soluble programmed cell death-1 ligand-1 (sPD-L1) with eosinophil count and clinical severity in allergic rhinitis patients. Allergol Int. 2017;66(2):326\u201331.","journal-title":"Allergol Int"},{"issue":"4","key":"2217_CR73","first-page":"384","volume":"55","author":"SL Wen","year":"2020","unstructured":"Wen SL, Li F, Zhao F, et al. [Programmed cell death protein 1 and its ligands regulate immune balance in allergic rhinitis]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020;55(4):384\u201390.","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"issue":"8","key":"2217_CR74","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1136\/bjo.2006.091314","volume":"90","author":"A Fukushima","year":"2006","unstructured":"Fukushima A, Yamaguchi T, Azuma M, et al. Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in mice. Br J Ophthalmol. 2006;90(8):1040\u20135.","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"2217_CR75","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nri.2016.111","volume":"16","author":"W Yu","year":"2016","unstructured":"Yu W, Freeland DMH, Nadeau KC. Food allergy: immune mechanisms, diagnosis and immunotherapy. Nat Rev Immunol. 2016;16(12):751\u201365.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2217_CR76","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.jaci.2016.02.004","volume":"137","author":"RS Chinthrajah","year":"2016","unstructured":"Chinthrajah RS, Hernandez JD, Boyd SD, et al. Molecular and cellular mechanisms of food allergy and food tolerance. J Allergy Clin Immunol. 2016;137(4):984\u201397.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2217_CR77","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12016-018-8710-3","volume":"57","author":"S Anvari","year":"2019","unstructured":"Anvari S, Miller J, Yeh C-Y, et al. IgE-Mediated food allergy. Clin Rev Allergy Immunol. 2019;57(2):244\u201360.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"2217_CR78","first-page":"371","volume":"23","author":"O Palomares","year":"2013","unstructured":"Palomares O. The role of regulatory T cells in IgE-mediated food allergy. J Investig Allergol Clin Immunol. 2013;23(6):371\u201382. quiz 2 p preceding 382.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"4","key":"2217_CR79","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1172\/JCI124605","volume":"129","author":"V Sampath","year":"2019","unstructured":"Sampath V, Nadeau KC. Newly identified T cell subsets in mechanistic studies of food immunotherapy. J Clin Invest. 2019;129(4):1431\u201340.","journal-title":"J Clin Invest"},{"issue":"9","key":"2217_CR80","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1182\/blood-2003-03-0727","volume":"102","author":"B Dubois","year":"2003","unstructured":"Dubois B, Chapat L, Goubier A, et al. Innate CD4\u2009+\u2009CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8\u2009+\u2009T cells mediating skin inflammation. Blood. 2003;102(9):3295\u2013301.","journal-title":"Blood"},{"issue":"10","key":"2217_CR81","doi-asserted-by":"publisher","first-page":"100969","DOI":"10.1016\/j.waojou.2024.100969","volume":"17","author":"J Huang","year":"2024","unstructured":"Huang J, Wang X, Zhang J, et al. Fecal microbiota transplantation alleviates food allergy in neonatal mice via the PD-1\/PD-L1 pathway and change of the microbiota composition. World Allergy Organ J. 2024;17(10):100969.","journal-title":"World Allergy Organ J"},{"key":"2217_CR82","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12098-017-2535-6","volume":"85","author":"JM Devdas","year":"2018","unstructured":"Devdas JM, Mckie C, Fox AT, et al. Food allergy in children: an overview. Indian J Pediatr. 2018;85:369\u201374.","journal-title":"Indian J Pediatr"},{"issue":"1","key":"2217_CR83","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jaci.2004.11.008","volume":"115","author":"M Chehade","year":"2005","unstructured":"Chehade M, Mayer L. Oral tolerance and its relation to food hypersensitivities. J Allergy Clin Immunol. 2005;115(1):3\u201312.","journal-title":"J Allergy Clin Immunol"},{"key":"2217_CR84","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12016-018-8680-5","volume":"55","author":"L Tordesillas","year":"2018","unstructured":"Tordesillas L, Berin MC. Mechanisms of oral tolerance. Clin Rev Allergy Immunol. 2018;55:107\u201317.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"2217_CR85","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jaci.2008.10.011","volume":"123","author":"K Ganeshan","year":"2009","unstructured":"Ganeshan K, Neilsen CV, Hadsaitong A, et al. Impairing oral tolerance promotes allergy and anaphylaxis: a new murine food allergy model. J Allergy Clin Immunol. 2009;123(1):231\u20138. e4.","journal-title":"J Allergy Clin Immunol"},{"key":"2217_CR86","doi-asserted-by":"crossref","unstructured":"Hamad A, Burks W, editors. Oral tolerance and allergy. Seminars in Immunology. Elsevier; 2017.","DOI":"10.1016\/j.smim.2017.07.001"},{"issue":"12","key":"2217_CR87","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1002\/eji.200425197","volume":"34","author":"E Oflazoglu","year":"2004","unstructured":"Oflazoglu E, Swart DA, Anders-Bartholo P, et al. Paradoxical role of programmed death\u20101 ligand 2 in Th2 immune responses in vitro and in a mouse asthma model in vivo. Eur J Immunol. 2004;34(12):3326\u201336.","journal-title":"Eur J Immunol"},{"key":"2217_CR88","doi-asserted-by":"publisher","first-page":"660974","DOI":"10.3389\/fimmu.2021.660974","volume":"12","author":"G Liu","year":"2021","unstructured":"Liu G, Liu M, Wang J, et al. The role of regulatory T cells in epicutaneous immunotherapy for food allergy. Front Immunol. 2021;12:660974.","journal-title":"Front Immunol"},{"issue":"13","key":"2217_CR89","first-page":"2266","volume":"116","author":"T Fukaya","year":"2010","unstructured":"Fukaya T, Takagi H, Sato Y, et al. Crucial roles of B7-H1 and B7-DC expressed on mesenteric lymph node dendritic cells in the generation of antigen-specific CD4\u2009+\u2009Foxp3+ regulatory T cells in the establishment of oral tolerance. Blood J Am Soc Hematol. 2010;116(13):2266\u201376.","journal-title":"Blood J Am Soc Hematol"},{"issue":"1","key":"2217_CR90","doi-asserted-by":"publisher","first-page":"ltab017","DOI":"10.1093\/immadv\/ltab017","volume":"1","author":"N Pinheiro-Rosa","year":"2021","unstructured":"Pinheiro-Rosa N, Torres L, Oliveira MA, et al. Oral tolerance as antigen-specific immunotherapy. Immunotherapy Adv. 2021;1(1):ltab017.","journal-title":"Immunotherapy Adv"},{"issue":"4","key":"2217_CR91","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.alit.2019.02.012","volume":"68","author":"T Manabe","year":"2019","unstructured":"Manabe T, Sato S, Yanagida N, et al. Long-term outcomes after sustained unresponsiveness in patients who underwent oral immunotherapy for egg, cow\u2019s milk, or wheat allergy. Allergology Int. 2019;68(4):527\u20138.","journal-title":"Allergology Int"},{"issue":"2 Suppl 2","key":"2217_CR92","doi-asserted-by":"publisher","first-page":"S138","DOI":"10.1016\/j.jaci.2009.05.039","volume":"125","author":"LS Fonacier","year":"2010","unstructured":"Fonacier LS, Dreskin SC, Leung DY. Allergic skin diseases. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S138\u201349.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"2217_CR93","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11882-024-01147-9","volume":"24","author":"K Faraz","year":"2024","unstructured":"Faraz K, Seely M, Marano AL. The role of the environment in allergic skin disease. Curr Allergy Asthma Rep. 2024;24(6):323\u201330.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"2217_CR94","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.clindermatol.2011.01.006","volume":"29","author":"C Bangert","year":"2011","unstructured":"Bangert C, Brunner PM, Stingl G. Immune functions of the skin. Clin Dermatol. 2011;29(4):360\u201376.","journal-title":"Clin Dermatol"},{"key":"2217_CR95","doi-asserted-by":"crossref","unstructured":"Patel AB, Pacha O. Skin reactions to immune checkpoint inhibitors. Immunotherapy. 2018:117\u201329.","DOI":"10.1007\/978-3-030-02505-2_5"},{"issue":"1","key":"2217_CR96","first-page":"1","volume":"37","author":"MR Gaudinski","year":"2017","unstructured":"Gaudinski MR, Milner JD. Atopic dermatitis and allergic urticaria: cutaneous manifestations of immunodeficiency. Immunol Allergy Clin. 2017;37(1):1\u201310.","journal-title":"Immunol Allergy Clin"},{"key":"2217_CR97","doi-asserted-by":"crossref","unstructured":"Lai X, Huang J, Li Y et al. Symbiotic bacteria-mediated imbalance and repair of immune homeostasis: exploring novel mechanisms of microbiome-host interactions in atopic dermatitis. Front Immunol. 2025;16.","DOI":"10.3389\/fimmu.2025.1649857"},{"issue":"16","key":"2217_CR98","doi-asserted-by":"publisher","first-page":"8403","DOI":"10.3390\/ijms22168403","volume":"22","author":"L Blicharz","year":"2021","unstructured":"Blicharz L, Rudnicka L, Czuwara J, et al. The influence of microbiome dysbiosis and bacterial biofilms on epidermal barrier function in atopic dermatitis-an update. Int J Mol Sci. 2021;22(16):8403.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2217_CR99","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41572-022-00389-z","volume":"8","author":"P Kolkhir","year":"2022","unstructured":"Kolkhir P, Gim\u00e9nez-Arnau AM, Kulthanan K, et al. Urticaria Nat Reviews Disease Primers. 2022;8(1):61.","journal-title":"Urticaria Nat Reviews Disease Primers"},{"issue":"1","key":"2217_CR100","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jid.2021.06.026","volume":"142","author":"R Tanaka","year":"2022","unstructured":"Tanaka R, Ichimura Y, Kubota N, et al. Differential involvement of programmed cell death ligands in skin immune responses. J Invest Dermatology. 2022;142(1):145\u2013e1548.","journal-title":"J Invest Dermatology"},{"issue":"1","key":"2217_CR101","first-page":"64","volume":"13","author":"H Sadeghi","year":"2024","unstructured":"Sadeghi H, Ghaffari J, Rajabi J, et al. Evaluation of the immune checkpoints, TIM-3 and PD-1, as well as anti-inflammatory cytokines IL-10, and TGF-\u03b2 along with diseases activity in chronic spontaneous urticaria. Int J Mol Cell Med. 2024;13(1):64\u201378.","journal-title":"Int J Mol Cell Med"},{"key":"2217_CR102","doi-asserted-by":"publisher","first-page":"655958","DOI":"10.3389\/fimmu.2021.655958","volume":"12","author":"R Bonamichi-Santos","year":"2021","unstructured":"Bonamichi-Santos R, Aun MV, Kalil J, et al. PD-L1 Blockade during allergen sensitization inhibits the synthesis of specific antibodies and decreases mast cell activation in a murine model of active cutaneous anaphylaxis. Front Immunol. 2021;12:655958.","journal-title":"Front Immunol"},{"key":"2217_CR103","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3390\/molecules24061190","volume":"24","author":"HT Lee","year":"2019","unstructured":"Lee HT, Lee SH, Heo Y-S Molecular interactions of antibody drugs targeting PD-1, PD-L1, and CTLA-4 in immuno-oncology. Molecules. 2019;24:1190. . https:\/\/doi.org\/10.3390\/molecules24061190.","journal-title":"Molecules"},{"issue":"6","key":"2217_CR104","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3892\/ijo.2022.5364","volume":"60","author":"G Sun","year":"2022","unstructured":"Sun G, Liu H, Shi X, et al. Treatment of patients with cancer using PD\u20131\/PD\u2013L1 antibodies: adverse effects and management strategies (Review). Int J Oncol. 2022;60(6):74.","journal-title":"Int J Oncol"},{"issue":"2","key":"2217_CR105","doi-asserted-by":"publisher","first-page":"104330","DOI":"10.1016\/j.lpm.2025.104330","volume":"55","author":"D Fattore","year":"2025","unstructured":"Fattore D, Lauletta G, Pages C, et al. Update on dermatological toxicities of immune checkpoint inhibitors. Presse Med. 2025;55(2):104330.","journal-title":"Presse Med"},{"issue":"16","key":"2217_CR106","doi-asserted-by":"publisher","first-page":"10802","DOI":"10.3390\/ijms241612802","volume":"24","author":"K Pa\u0142gan","year":"2023","unstructured":"Pa\u0142gan K. Mast cells and basophils in IgE-independent anaphylaxis. Int J Mol Sci. 2023;24(16):10802.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2217_CR107","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.3390\/ijerph17082787","volume":"17","author":"I Poziomkowska-G\u0119sicka","year":"2020","unstructured":"Poziomkowska-G\u0119sicka I, Kurek M. Clinical manifestations and causes of anaphylaxis. Analysis of 382 cases from the anaphylaxis registry in West Pomerania Province in Poland. Int J Environ Res Public Health. 2020;17(8):2787.","journal-title":"Int J Environ Res Public Health"},{"key":"2217_CR108","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-1-60327-951-2_8","volume-title":"Anaphylaxis and Hypersensitivity Reactions","author":"FD Finkelman","year":"2011","unstructured":"Finkelman FD. IgE-Dependent and independent effector mechanisms in human and murine anaphylaxis. In: Castells MC, editor. Anaphylaxis and Hypersensitivity Reactions. Totowa, NJ: Humana; 2011. pp. 127\u201344."},{"issue":"2","key":"2217_CR109","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jaci.2017.06.003","volume":"140","author":"LL Reber","year":"2017","unstructured":"Reber LL, Hernandez JD, Galli SJ. The pathophysiology of anaphylaxis. J Allergy Clin Immunol. 2017;140(2):335\u201348.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2217_CR110","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00281-025-01056-7","volume":"47","author":"M Worm","year":"2025","unstructured":"Worm M, Pazur K, Morakabati P, et al. IgE and non-IgE-mediated pathways in anaphylaxis. Semin Immunopathol. 2025;47(1):34.","journal-title":"Semin Immunopathol"},{"issue":"1","key":"2217_CR111","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jaci.2022.01.014","volume":"150","author":"JK Lama","year":"2022","unstructured":"Lama JK, Iijima K, Kobayashi T, et al. Blocking the inhibitory receptor programmed cell death 1 prevents allergic immune response and anaphylaxis in mice. J Allergy Clin Immunol. 2022;150(1):178\u2013e1919.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2217_CR112","doi-asserted-by":"publisher","first-page":"12558","DOI":"10.1038\/s41598-021-91851-7","volume":"11","author":"A Vultaggio","year":"2021","unstructured":"Vultaggio A, Nencini F, Bormioli S, et al. Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis. Sci Rep. 2021;11(1):12558.","journal-title":"Sci Rep"},{"issue":"4","key":"2217_CR113","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3390\/cancers13040729","volume":"13","author":"AM Monjazeb","year":"2021","unstructured":"Monjazeb AM, Wang Z, Vick LV, et al. Mouse preclinical cancer immunotherapy modeling involving anti-PD-1 therapies reveals the need to use mouse reagents to mirror clinical paradigms. Cancers. 2021;13(4):729.","journal-title":"Cancers"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02217-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02217-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02217-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T09:02:45Z","timestamp":1775034165000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02217-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":113,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2217"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02217-6","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"7 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"75"}}